Used for
- Generative AI ApplicationsDrug discoveryMolecular structure designBiopharmaceutical researchMedicinal chemistry
Features
- Generative AI platformEarly access availableNovel molecule creationNo data requiredKinase target accessBiopharmaceutical collaborationFoundation model for small moleculesRapid lead structure generationProven experimental data integrationPatent-pending innovationsGenerative AI for drug discoveryFirst commercially accessible foundation model for small moleculesNovel molecule structure generationNo initial data requiredTrained on decades of experimental dataTarget Product Profile (TPP) definitionOn-target and off-target selectionSupports over 90 kinase targetsRapid lead structure creationCollaborative platform with biopharmaceutical partners
What is Variational.ai?
Variational.ai is a platform that uses generative AI to enhance drug discovery and development, focusing on novel molecule structure generation.What is the Enki™ platform?
The Enki™ platform is a foundational model for small molecules that facilitates the creation of novel lead structures using generative AI.How does Enki™ work?
Enki™ uses generative algorithms trained on decades of experimental data, allowing users to define their Target Product Profile and select target properties to generate novel molecule structures.Do I need initial data to use Enki™?
No, Enki™ does not require initial data. It leverages existing experimental data to generate results.What are the key features of the Enki™ platform?
Key features include generative AI for drug discovery, foundation model for small molecules, TPP definition, and support for over 90 kinase targets.Who can benefit from using Variational.ai?
Professionals such as medicinal chemists, computational chemists, biopharmaceutical researchers, AI researchers, and drug development specialists can benefit from using Variational.ai.What kind of targets does Enki™ support?
Enki™ supports over 90 kinase targets, including AXL, EGFRs, PIK3s, CDKs, and VEGFRs.How quickly can Enki™ generate lead structures?
Enki™ can generate novel and selective lead structures in about a week or two.Is Enki™ a collaborative platform?
Yes, Enki™ is designed for collaboration with biopharmaceutical partners to enhance drug discovery and development.How is Variational.ai transforming drug discovery?
Variational.ai uses state-of-the-art generative AI to redefine the unit economics of drug discovery and development, making the process more efficient and cost-effective.